* Q4 earnings per share view $-0.56 — Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

The post BRIEF-Global Blood Therapeutics Q4 loss per share $0.53 appeared first on NASDAQ.